153 related articles for article (PubMed ID: 12544697)
1. Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy.
Tursi A; Brandimarte G; Giorgetti G; Nasi G
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):69-74. PubMed ID: 12544697
[TBL] [Abstract][Full Text] [Related]
2. Orocecal transit time and bacterial overgrowth in patients with Crohn's disease.
Castiglione F; Del Vecchio Blanco G; Rispo A; Petrelli G; Amalfi G; Cozzolino A; Cuccaro I; Mazzacca G
J Clin Gastroenterol; 2000 Jul; 31(1):63-6. PubMed ID: 10914780
[TBL] [Abstract][Full Text] [Related]
3. Orocaecal transit time in patients with Crohn disease.
Götze H; Ptok A
Eur J Pediatr; 1993 Mar; 152(3):193-6. PubMed ID: 8444243
[TBL] [Abstract][Full Text] [Related]
4. Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
Dig Dis Sci; 2006 Mar; 51(3):461-5. PubMed ID: 16614952
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of lactulose plus 13C-acetate breath test in the diagnosis of gastrointestinal motility disorders.
Urita Y; Hike K; Torii N; Kikuchi Y; Sasajima M; Miki K
J Gastroenterol; 2002; 37(6):442-8. PubMed ID: 12108678
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous non-invasive measurement of liquid gastric emptying and small bowel transit by combined 13C-acetate and H2-lactulose breath test.
Bertram F; Andresen V; Layer P; Keller J
J Breath Res; 2014 Nov; 8(4):046007. PubMed ID: 25417651
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
[TBL] [Abstract][Full Text] [Related]
8. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
World J Gastroenterol; 2005 May; 11(18):2773-6. PubMed ID: 15884120
[TBL] [Abstract][Full Text] [Related]
9. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease.
Rana SV; Sharma S; Malik A; Kaur J; Prasad KK; Sinha SK; Singh K
Dig Dis Sci; 2013 Sep; 58(9):2594-8. PubMed ID: 23649377
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
[TBL] [Abstract][Full Text] [Related]
11. Gastric emptying and orocaecal transit time of meals containing lactulose or inulin in men.
Clegg M; Shafat A
Br J Nutr; 2010 Aug; 104(4):554-9. PubMed ID: 20370945
[TBL] [Abstract][Full Text] [Related]
12. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of the orocaecal transit time after an oral lactulose load--does the fasting breath hydrogen concentration affect the feasibility of the test?].
Jonderko K; Janikowska A; Kasicka-Jonderko A; Kotuła I; Błońska-Fajfrowska B
Wiad Lek; 2008; 61(4-6):107-12. PubMed ID: 18939360
[TBL] [Abstract][Full Text] [Related]
14. Influence of the substrate on the reproducibility of the hydrogen breath test to measure the orocecal transit time.
Casellas F; Malagelada J
Digestion; 1998; 59(6):696-702. PubMed ID: 9813396
[TBL] [Abstract][Full Text] [Related]
15. Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test.
Biancone L; Vernia P; Agostini D; Ferrieri A; Pallone F
Curr Med Res Opin; 2000; 16(1):14-20. PubMed ID: 16422030
[TBL] [Abstract][Full Text] [Related]
16. Does the initial location of Crohn's disease have an influence on the time-to-relapse in patients under maintenance treatment with oral mesalamine?
Bresci G; Parisi G; Bertoni M; Masolino P; Scatena F; Capria A
J Clin Gastroenterol; 2000 Sep; 31(2):147-51. PubMed ID: 10993432
[TBL] [Abstract][Full Text] [Related]
17. [The H2-lactulose breath test in the diagnosis of intestinal transit time].
Wilberg S; Pieramico O; Malfertheiner P
Leber Magen Darm; 1990 May; 20(3):129-37. PubMed ID: 2377020
[TBL] [Abstract][Full Text] [Related]
18. Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients.
Gemignani L; Savarino V; Ghio M; Parodi A; Zentilin P; de Bortoli N; Negrini S; Furnari M; Dulbecco P; Giambruno E; Savarino E
Semin Arthritis Rheum; 2013 Apr; 42(5):522-9. PubMed ID: 23352249
[TBL] [Abstract][Full Text] [Related]
19. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
Clemett D; Markham A
Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
[TBL] [Abstract][Full Text] [Related]
20. The inulin hydrogen breath test accurately reflects orocaecal transit time.
Schneider AR; Jepp K; Murczynski L; Biniek U; Stein J
Eur J Clin Invest; 2007 Oct; 37(10):802-7. PubMed ID: 17727672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
